Codexis to Report First Quarter 2024 Financial Results on May 2
REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced […]
WANG & LEE GROUP, INC. Announces Fiscal Year 2023 Financial Results
HONG KONG, China, April 18, 2024 (GLOBE NEWSWIRE) — WANG & LEE GROUP, Inc. (Nasdaq: WLGS) (“WLGS” or the “Company”), […]
Altair Announces Date of First Quarter 2024 Financial Results Conference Call
TROY, Mich., April 18, 2024 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global leader in computational intelligence, will release its financial […]
LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May 2, 2024
SALT LAKE CITY, April 18, 2024 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products […]
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate […]
Enlight to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) — Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT, TASE: ENLT.TA), a leading global […]
Aware Sets First Quarter 2024 Webcast for Thursday, May 2, 2024 at 5:00 p.m. Eastern Time
BURLINGTON, Mass., April 18, 2024 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data […]
Gaia Sets First Quarter 2024 Conference Call for Monday, May 6, 2024, at 4:30 p.m. ET
BOULDER, Colo., April 18, 2024 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA) (“Gaia” and/or the “Company”), a conscious media and […]
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that […]
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
MIAMI, April 18, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing […]
